Gladstone Commercial Corporation Earnings Call and Webcast Information
MCLEAN, VA / ACCESSWIRE / August 5, 2024 / Gladstone Commercial Corporation (Nasdaq:GOOD) announces the following event:
What: | Gladstone Commercial Corporation's Second Quarter Ended | |
When: | Wednesday, August 7, 2024 @ 8:30 a.m. ET | |
Website: | https://event.choruscall.com/mediaframe/webcast.html?webcastid=59elICYx | |
How: | By webcast -- Log on to the web at the address above | |
By phone -- Please call (877) 424-3437 | ||
Contact: | Gladstone Commercial Corporation, (703) 287-5893 |
A conference call replay will be available after the call and will be accessible through August 14, 2024. To hear the replay, please dial (877) 660-6853 and use playback conference number 13746756.
If you are unable to participate during the live webcast, the call will also be archived on our website (www.gladstonecommercial.com).
Gladstone Commercial Corporation is a real estate investment trust ("REIT") focused on acquiring, owning and operating net leased industrial and office properties across the United States. Additional information can be found at www.gladstonecommercial.com.
For further information: Gladstone Commercial Corporation, (703) 287-5893
SOURCE: Gladstone Commercial Corporation
View the original press release on accesswire.com
-
6 Top-Performing Large-Growth Funds
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks